Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.61
+0.53 (4.39%)
At close: Jan 29, 2026, 4:00 PM EST
12.61
0.00 (0.00%)
After-hours: Jan 29, 2026, 4:00 PM EST
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $427 million as of January 29, 2026. Its market cap has increased by 77.02% in one year.
Market Cap
427.00M
Enterprise Value
333.34M
1-Year Change
77.02%
Ranking
Category
Stock Price
$12.61
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $427.00M, a decrease of -80.82%. That is a compound annual growth rate of -13.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 409.06M | -10.32% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 436.09M |
| Absci | 434.57M |
| Assembly Biosciences | 432.44M |
| Greenwich LifeSciences | 424.23M |
| vTv Therapeutics | 420.16M |
| Zura Bio | 414.85M |
| Aclaris Therapeutics | 413.88M |
| Entrada Therapeutics | 398.06M |